Antifungal Use in Oncohematological Neutropenic Patients
Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
Primary purpose: Frequency of use of broad-spectrum antifungals in the episode of
neutropenia.
Secondary purposes:To determine the safety and toxicity measure by:
1. Frequency of Invader Fungal Infection.
2. Frequency of global use of broad-spectrum antifungals as amphotericine, itraconazole,
voriconazole, caspofungin, terbinafine, during the period of study.
3. Mortality
4. Development of nephrotoxicity
5. Use of galactomannan in this clinical context
6. Time of administration of empirical antifungal therapy of broad-spectrum.